Tags

Type your tag names separated by a space and hit enter

Open-angle glaucoma.
Am Fam Physician 2003; 67(9):1937-44AF

Abstract

Glaucoma is the second most common cause of legal blindness in the United States. Open-angle glaucoma is an asymptomatic, progressive optic neuropathy characterized by enlarging optic disc cupping and visual field loss. Patients at increased risk for open-angle glaucoma include blacks older than 40 years, whites older than 65 years, and persons with a family history of glaucoma or a personal history of diabetes or severe myopia. Elevated intraocular pressure is a strong, modifiable risk factor for open-angle glaucoma, but it is not diagnostic. Some patients with glaucoma have normal intraocular pressure (i.e., normal-pressure glaucoma), and many patients with elevated intraocular pressure do not have glaucoma (i.e., glaucoma suspects). Routine measurement of intraocular pressure by primary care physicians to screen patients for glaucoma is not recommended. Open-angle glaucoma usually is discovered during an adult eye evaluation performed for other indications. Final diagnosis and treatment occur in collaboration with ophthalmologists and optometrists. Formal visual field testing (perimetry) is a mainstay of glaucoma diagnosis and management. Eye drops, commonly nonspecific beta-blocker or prostaglandin analog drops, generally are the first-line treatment to reduce intraocular pressure. Laser treatment and surgery usually are reserved for patients in whom medical treatment has failed. Without treatment, open-angle glaucoma can end in irreversible vision loss.

Authors+Show Affiliations

Milliman Care Guidelines, Division of Milliman, Seattle, Washington 98104, USA. jim.distelhorst@milliman.comNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

12751655

Citation

Distelhorst, James S., and Grady M. Hughes. "Open-angle Glaucoma." American Family Physician, vol. 67, no. 9, 2003, pp. 1937-44.
Distelhorst JS, Hughes GM. Open-angle glaucoma. Am Fam Physician. 2003;67(9):1937-44.
Distelhorst, J. S., & Hughes, G. M. (2003). Open-angle glaucoma. American Family Physician, 67(9), pp. 1937-44.
Distelhorst JS, Hughes GM. Open-angle Glaucoma. Am Fam Physician. 2003 May 1;67(9):1937-44. PubMed PMID: 12751655.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Open-angle glaucoma. AU - Distelhorst,James S, AU - Hughes,Grady M, PY - 2003/5/20/pubmed PY - 2003/6/18/medline PY - 2003/5/20/entrez SP - 1937 EP - 44 JF - American family physician JO - Am Fam Physician VL - 67 IS - 9 N2 - Glaucoma is the second most common cause of legal blindness in the United States. Open-angle glaucoma is an asymptomatic, progressive optic neuropathy characterized by enlarging optic disc cupping and visual field loss. Patients at increased risk for open-angle glaucoma include blacks older than 40 years, whites older than 65 years, and persons with a family history of glaucoma or a personal history of diabetes or severe myopia. Elevated intraocular pressure is a strong, modifiable risk factor for open-angle glaucoma, but it is not diagnostic. Some patients with glaucoma have normal intraocular pressure (i.e., normal-pressure glaucoma), and many patients with elevated intraocular pressure do not have glaucoma (i.e., glaucoma suspects). Routine measurement of intraocular pressure by primary care physicians to screen patients for glaucoma is not recommended. Open-angle glaucoma usually is discovered during an adult eye evaluation performed for other indications. Final diagnosis and treatment occur in collaboration with ophthalmologists and optometrists. Formal visual field testing (perimetry) is a mainstay of glaucoma diagnosis and management. Eye drops, commonly nonspecific beta-blocker or prostaglandin analog drops, generally are the first-line treatment to reduce intraocular pressure. Laser treatment and surgery usually are reserved for patients in whom medical treatment has failed. Without treatment, open-angle glaucoma can end in irreversible vision loss. SN - 0002-838X UR - https://www.unboundmedicine.com/medline/citation/12751655/full_citation L2 - http://www.aafp.org/link_out?pmid=12751655 DB - PRIME DP - Unbound Medicine ER -